C

IPSC

Century Therapeutics, Inc.

0.56

0.01+2.02%
After Hours: 0.5700  +0.0089  +1.59%19:53 05/05 EDT

Financial Statements

Statement:

Key indicator

Income Statement

Balance Sheet

Cash Flow

Reporting Period:

Accumulated Report

FY

YoY:
FY: Financial Year Annual Report
Q: Quarter is quarterly reports. Q1, Q2, Q3 and Q4 are reports for a single quarter. Q6 and Q9 are accumulated quarterly reports, respectively contain 6 months' reports and 9 months' report.
Item
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Cash from Operating Activities

-110.14M

-88.35M

14.05M

-89.00M

-41.27M

Net Income

-126.57M

-136.67M

-130.93M

-95.82M

-53.58M

Depreciation/Depletion & Amortization

13.30M

13.04M

8.44M

3.75M

1.40M

Deferred Taxes

--

--

--

--

--

Non-Cash Items

11.54M

26.12M

13.10M

6.66M

4.54M

Changes in Working Capital

-8.41M

9.16M

123.44M

-3.58M

6.37M

Cash from Investing Activities

47.48M

61.13M

-13.13M

-298.34M

-22.76M

Capital Expenditures

-154.00K

-13.74M

-30.60M

-44.97M

-14.55M

Other Investing Cash Flow Items, Total

47.64M

74.87M

17.48M

-253.37M

-8.21M

Cash from Financing Activities

74.56M

-9.72M

27.16M

417.77M

47.69M

Financing Cash Flow Items

--

--

0

34.23M

37.96M

Total Cash Dividends Paid

--

--

--

--

--

Issuance (Retirement) of Stock, Net

74.56M

516.00K

27.16M

383.55M

0

Issuance (Retirement) of Debt, Net

--

-10.24M

--

0

9.73M

Foreign Exchange Effects

--

--

--

--

--

Net Change in Cash

11.91M

-36.94M

28.08M

30.43M

-16.34M

Cash Interest Paid

0

586.00K

1.10M

969.00K

207.00K

Cash Taxes Paid

501.00K

--

--

--

--